Navigation Links
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Date:9/4/2007

SAN DIEGO, Sept. 4 /PRNewswire/ -- Takeda San Diego announced today that Keith Wilson, Ph.D. has been named president and chief scientific officer (CSO). In this position, he is responsible for overseeing all activities related to Takeda San Diego, Takeda Pharmaceutical Company Limited's U.S.-based drug discovery company.

"Dr. Wilson has been an important part of Takeda San Diego for several years and brings a wealth of scientific excellence to Takeda," said Shigenori Ohkawa, Ph.D., general manager, pharmaceutical research division, Takeda Pharmaceutical Company Limited. "His leadership has been instrumental in focusing the company on drug discovery and building the Takeda San Diego pipeline, and we look forward to his vital contributions in this new role."

Before being named president and CSO at Takeda San Diego, Dr. Wilson served dual roles as vice president of structural biology and vice president of business development. Prior to joining Takeda, he also spent a decade with Vertex Pharmaceuticals co-leading drug discovery programs and significant alliance projects.

Dr. Wilson has formal training in protein X-ray crystallography, and has a doctorate degree in physics from the University of Oregon and a bachelor's degree in physics from Colby College, where he graduated magna cum laude and was awarded the William A. Rogers prize in physics. Dr. Wilson is a contributing author on more than 30 peer-reviewed publications and co-inventor of six issued U.S. patents covering multiple drug candidates.

About Takeda San Diego, Inc.

Takeda San Diego is Takeda's first U.S.-based discovery research operation. Takeda San Diego achieves an advantage in drug discovery by leveraging its leading structural biology capabilities to determine the three dimensional structures of drug targets ahead of competitors and then uses these structures to efficiently create best-in-class drug candidates to treat diabetes, cancer, and other important diseases. Visit http://www.takedasd.com to learn more.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, http://www.takeda.com.


'/>"/>
SOURCE Takeda Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. CEO Wilson Defines GEs Health-IT Customer
2. Bruce Maas named CIO at UW-Milwaukee
3. Three finalists named for UW-Madison CIO
4. Eight lawmakers named to Speakers IT task force
5. Hospital named for Madame Curie installs TomoTherapy system
6. Two UW-Madison professors named to National LambdaRail Networking Research Council
7. UW researcher named top innovator
8. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
9. Inacom named Microsofts favorite learning solutions partner of the year
10. Five Wisconsin CIOs named top in nation
11. Deltanoid named to top-15 list of biotech companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, Inc. ... it has initiated a global Phase 2b induction ... peptide that targets alpha4beta7 integrin. The aim of ... to evaluate the safety/tolerability and efficacy of PTG-100 ... moderate to severe active disease. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Attagene , a Research ... U.S. Small Business Administration. The Tibbetts Award honors the Small Business Innovation ... and are considered the best of the best from the thousands of firms ...
(Date:1/13/2017)... -- Research and Markets has announced the addition of ... to 2021" report to their offering. ... The biosimilars market is expected to ... 2016, at a CAGR of 26.3%. The global ... and application. Factors such as rising incidence of various diseases, increasing ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology:
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
Breaking Biology News(10 mins):